Tessera Therapeutics
Divya Ramamoorthy is a Machine Learning Scientist II at Tessera Therapeutics, where developments include a Bayesian approximation algorithm that significantly reduced screening costs and turn-around time. Prior to this role, Divya served as a Machine Learning Scientist I at the Massachusetts Institute of Technology, concentrating on Bayesian models for clinical data and mentoring undergraduate researchers. Notable internships include work at Novartis Institutes for BioMedical Research and IBM, focusing on CAR-T therapy modeling and cloud services development, respectively. Divya holds a PhD in Biological Engineering from MIT and dual Bachelor’s degrees in Biomedical Engineering and Plan II Honors from The University of Texas at Austin.
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.